期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Checkpoint immunotherapy for NK/T cell lymphoma—Time for a showdown?
1
作者 jason yongsheng chan Jing Quan Lim Choon Kiat Ong 《Precision Clinical Medicine》 2021年第1期70-72,共3页
Editor’s note A commentary on“Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma”.Extranodal natural killer/T-cell lymphoma(ENKT... Editor’s note A commentary on“Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma”.Extranodal natural killer/T-cell lymphoma(ENKTL)is an uncommon and aggressive subtype of non-Hodgkin lymphoma with a geographic distribution unique to East Asia and Latin America. 展开更多
关键词 immune checkpoint inhibitor CHEMOIMMUNOTHERAPY PD-1 nasal lymphoma
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部